Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / COM
-
Number of holders
-
39
-
Total 13F shares, excl. options
-
1,205,011
-
Shares change
-
-360,220
-
Total reported value, excl. options
-
$7,627,293
-
Value change
-
-$2,444,937
-
Number of buys
-
25
-
Number of sells
-
28
-
Price
-
$6.33
Institutional Holders of Nuvectis Pharma, Inc. - COM (NVCT) as of Q2 2024
As of 30 Jun 2024 Nuvectis Pharma, Inc. - COM (NVCT) had 39 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,205,011 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BALDWIN BROTHERS LLC/MA, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, GOLDMAN SACHS GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, GSA CAPITAL PARTNERS LLP, and FORBES J M & CO LLP.
This table shows 40 institutional shareholders of the security as of 30 Jun 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.